Spyre Therapeutics, Inc. (SYRE)
69.42
-5.03
(-6.76%)
USD |
NASDAQ |
May 01, 16:00
71.09
+1.67
(+2.41%)
After-Hours: 20:00
Spyre Therapeutics EPS Diluted (Quarterly) : -0.6903 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.5655 |
| Replimune Group, Inc. | -0.7694 |
| Savara, Inc. | -0.1341 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Agios Pharmaceuticals, Inc. | -1.686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.83M |
| Total Expenses (Quarterly) | 51.83M |
| Enterprise Value | 4.852B |
| Earnings Yield | -2.99% |
| Normalized Earnings Yield | -3.127 |